“…21 While biocatalysis has proved successful in enantioselective C(sp 3 )−H amination, 22 highly enantioselective protocols using small molecules have been dominated by precious metal catalysis (Ir, Rh, Ru), 23 and the few Fe-catalyzed variants have been limited in enantioselectivity and scope 20 until the recent publication from Dang, Liu, and Che. 24 Thanks to a newly developed panel of porphyrin ligands involving either or both sterically demanding octahydro-1,4:5,8-dimethanoanthracene-9-yl groups and amide hydrogen-bond donors, moderate to good enantioselectivities were obtained for a broad range of indolines (39−90% ee = enantiomeric excess) and sultams (30−93% ee, Scheme 5). A synergistic effect between the two types of substituents was found to occur in the most efficient catalyst, with steric distortion being the main factor in determining the selectivity.…”